MedPath

LABORATOIRE CHAUVIN

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

3

CIMA_AEMPS:3

Drug Approvals

LIPOLASIC 2 mg/g GEL OFTALMICO

Approval Date
Jul 14, 2025
CIMA_AEMPS

LIPOLASIC 2 MG/G GEL OFTALMICO

Approval Date
Jul 14, 2025
CIMA_AEMPS

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

A Study to Evaluate the Performance and Safety of CBL-102 Versus Vismed® Multi Eye Drops in the Management of Dry Eye

Not Applicable
Completed
Conditions
Dry Eye
First Posted Date
2017-12-11
Last Posted Date
2025-05-14
Lead Sponsor
Laboratoire Chauvin
Target Recruit Count
92
Registration Number
NCT03368404
Locations
🇫🇷

Hôpital Kremlin-Bicêtre, Le Kremlin-Bicêtre, France

A Study to Evaluate the Performance and Safety of CBL-101 Versus Vismed® Multi Eye Drops in the Management of Dry Eye

Not Applicable
Completed
Conditions
Dry Eye
First Posted Date
2016-11-29
Last Posted Date
2024-06-24
Lead Sponsor
Laboratoire Chauvin
Target Recruit Count
87
Registration Number
NCT02975102
Locations
🇧🇪

Dr. Nyst private office, Huy, Belgium

🇫🇷

Pr Mortemousque private office, Bordeaux, France

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.